Halozyme Therapeutics
HALO
#2332
Rank
โ‚ฌ6.58 B
Marketcap
55,77ย โ‚ฌ
Share price
0.60%
Change (1 day)
-2.44%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): โ‚ฌ0.66 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚ฌ1.24 Billion. In 2024 the company made an earning of โ‚ฌ0.48 Billion, an increase over its 2023 earnings that were of โ‚ฌ0.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.66 B36.96%
2024 โ‚ฌ0.48 B59.94%
2023 โ‚ฌ0.30 B39.94%
2022 โ‚ฌ0.21 B0.16%
2021 โ‚ฌ0.21 B92.2%
2020 โ‚ฌ0.11 B-278.96%
2019 -โ‚ฌ62.94 Million-9.45%
2018 -โ‚ฌ69.5 Million-229.51%
2017 โ‚ฌ53.66 M-160.48%
2016 -โ‚ฌ88.73 Million216.03%
2015 -โ‚ฌ28.08 Million-52.86%
2014 -โ‚ฌ59.56 Million-18.09%
2013 -โ‚ฌ72.71 Million55.88%
2012 -โ‚ฌ46.65 Million169.94%
2011 -โ‚ฌ17.28 Million-63.44%
2010 -โ‚ฌ47.26 Million-7.19%
2009 -โ‚ฌ50.92 Million15.91%
2008 -โ‚ฌ43.93 Million83.89%
2007 -โ‚ฌ23.89 Million78.1%
2006 -โ‚ฌ13.42 Million16%
2005 -โ‚ฌ11.57 Million45.24%
2004 -โ‚ฌ7.97 Million682.42%
2003 -โ‚ฌ1.02 Million1659.12%
2002 -โ‚ฌ0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.21 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.32 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.60 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.92 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚ฌ0.24 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ26.81 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA